Dual synergistic effect: The effect of dexamethasone plus carnitine on skin flap survival

Annals of Plastic Surgery

Volumn 53, Issue 5, 2004, Pages 488-491

  Kargi, Eksal ^a   Deren, Orgun ^b   Babuccu, Orhan ^a   Hosnuter, Mubin ^a   Erdogan, Bulent ^b  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b ANKARA NUMUNE HOSPITAL   (Turkey)

Author keywords

Carnitine; Dexamethasone; Dual effect; Experimental; Flap survival; Skin flap

Indexed keywords

CARNITINE; DEXAMETHASONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; GRAFT SURVIVAL; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; SKIN FLAP; SURGICAL TECHNIQUE; SUTURE; TREATMENT OUTCOME;

ANIMALS; CARNITINE; DEXAMETHASONE; DRUG SYNERGISM; ISCHEMIA; RATS; RATS, SPRAGUE-DAWLEY; SURGICAL FLAPS;

EID: 7044260909     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sap.0000136975.69733.1f     Document Type: Article

References (33)

1. Huemer GM, Wechselberger G, Otto-Schoeller A, et al. Improved dorsal random-pattern skin flap survival in rats with a topically applied combination of nonivamide and nicoboxil. Plast Reconstr Surg. 2003;111:1207-1211.
2. Matsumura H, Yoshizawa N, Vedder NB, et al. Preconditioning of the distal portion of a rat random-pattern skin flap. Br J Plast Surg. 2001;54:58-61.
3. Uhl E, Barker JH, Bondar I, et al. Improvement of skin flap perfusion by subdermal injection of recombinant human basic fibroblast growth factor. Ann Plast Surg. 1994;32:361-365.
4. Cetinkale O, Sengul R, Bilgic L, et al. Involvement of neutrophils in ischemic injury, I: biochemical and histopathological investigation of the effect of FK506 on dorsal skin flaps in rats. Ann Plast Surg. 1997;39:505-515.
5. th ed. London: WB Saunders; 1994:1-34.
6. Picard-Ami LA Jr, MacKay A, Kerrigan CL. Pathophysiology of ischemic skin flaps: differences in xanthine oxidase levels among rats, pigs, and humans. Plast Reconstr Surg. 1991;87:750-755.
7. Rees R, Smith D, Li TD, et al. The role of xanthine oxidase and xanthine dehydrogenase in skin ischemia. J Surg Res. 1994;56:162-167.
8. de la Ossa JC, Malago M, Gewertz BL. Neutrophil-endothelial cell binding in neutrophil-mediated tissue injury. J Surg Res. 1992;53:103-107.
9. Arslan E, Milcan A, Unal S, et al. The effects of carnitine on distally-burned dorsal skin flap: an experimental study in rats. Burns. 2003;29:221-227.
10. Brevetti G, Perna S. Metabolic and clinical effects of L-carnitine in peripheral vascular disease. In: Ferrari R, DiMauro S, Sherwood G, eds. L-Carnitine and Its Role in Medicine: From Function to Therapy. London: Academic Press; 1992:359-378.
11. Tellioǧlu AT, Uras KA, Yilmaz T, et al. The effect of carnitine on random-pattern flap survival in rats. Plast Reconstr Surg. 2001;108:959-962.
12. Asian G, Karacal N, Gorgu M, et al. Nonsurgical delay of cutaneous flaps using the flashlamp pumped pulsed dye laser. Ann Plast Surg. 2000;44:277-281.
13. Ercocen AR, Apaydin I, Emiroglu M, et al. The effects of L-arginine and iloprost on the viability of random skin flaps in rats. Scand J Plast Reconstr Surg Hand Surg. 1998;32:19-25.
14. Hosnuter M, Babuccu O, Kargi E, et al. Dual preconditioning: effects of pharmacological plus ischemic preconditioning on skin flap survival. Ann Plast Surg. 2003;50:398-402.
15. Gribbe O, Lundeberg T, Samuelson UE, et al. Dexamethasone increases survival and attenuates induction of inducible nitric oxide synthase in experimental skin flaps. Ann Plast Surg. 1999;42:180-184.
16. Torkvist L, Lundeberg T, Thorlacius H, et al. Effects of environmental stress on tissue survival and neutrophil recruitment in surgical skin flaps in relation to plasma corticosterone levels in the rat. Inflamm Res. 1997;46:199-202.
17. Willemart G, Knight KR, Ayad M, et al. The beneficial antiinflammatory effect of dexamethasone administration prior to reperfusion on the viability of cold-stored skin flaps. Int J Tissue React. 1999;21:71-78.
18. Willemart G, Knight KR, Morrison WA. Dexamethasone treatment prior to reperfusion improves the survival of skin flaps subjected to secondary venous ischaemia. Br J Plast Surg. 1998;51:624-628.
19. Esclamado RM, Larrabee WF Jr, Zel GE. Efficacy of steroids and hyperbaric oxygen on survival of dorsal skin flaps in rats. Otolaryngol Head Neck Surg. 1990;102:41-44.
20. Zarem HA, Soderberg R. Tissue reaction to ischemia in the rabbit ear chamber: effects of prednisolone on inflammation and microvascular flow. Plast Reconstr Surg. 1982;70:667-676.
21. Arsenian MA. Carnitine and its derivatives in cardiovascular disease. Prog Cardiovasc Dis. 1997;40:265-286.
22. Hagen TM, Moreau R, Suh JH, et al. Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-L-carnitine and/or lipoic acid. Ann N Y Acad Sci. 2002;959:491-507.
23. Harris RL, Frenkel RA, Cottam GL, et al. Lipid mobilization and metabolism after thermal trauma. J Trauma. 1982;22:194-198.
24. Corsi C, Pollastri M, Marrapodi E, et al. L-Propionylcarnitine effect on postexercise and postischemic hyperemia in patients affected by peripheral vascular disease. Angiology. 1995;46:705-713.
25. Visioli O, Pasini E, de Giuli F, et al. Molecular mechanism of action of L-carnitine in treatment of myocardial disorders at the experimental level. In: Ferrari R, DiMauro S, Sherwood G, eds. L-Carnitine and Its Role in Medicine: From Function to Therapy. London: Academic Press; 1992:237-263.
26. Aisaka K, Gross SS, Griffith OW, et al. L-Arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo. Biochem Biophys Res Commun. 1989;163:710-717.
27. th ed. Stamford: Appleton & Lange; 2000:160-171.
28. Pata YS, Akbas Y, Unal M, et al. Prevention of laryngotracheal stenosis with carnitine after tracheotomy: an experimental study on rats. Int J Pediatr Otorhinolaryngol. 2003;67:881-888.
29. Hulsmann WC, Dubelaar M. L-Carnitine in metabolism of paced cardiac and skeletal muscles: prevention of acidosis and improvement of vascular flow. In: Ferrari R, DiMauro S, Sherwood G, eds. L-Carnitine and Its Role in Medicine: From Function to Therapy. London: Academic Press; 1992:345-358.
30. Muraki K, Imaizumi Y. A novel action of palmitoyl-L-carnitine in human vascular endothelial cells. J Pharmacol Sci. 2003;92:252-258.
31. Pola P, De Martini D, Gerardino L, et al. The action of propionyl-L-carnitine on the vasal endothelium: increased t-PA synthesis and a decrease in the activity of PAI-1: a preliminary study. Drugs Exp Clin Res. 1992;18:343-348.
32. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
33. Abdih H, Kelly CJ, Bouchier-Hayes D, et al. Nitric oxide (endothelium-derived relaxing factor) attenuates revascularization-induced lung injury. J Surg Res. 1994;57:39-43.